ab23875 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab23875 は 11 報の論文で使用されています。

  • Zhou T  et al. Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biol 21:101120 (2019). PubMed: 30708325
  • Xiang HC  et al. AMPK activation attenuates inflammatory pain through inhibiting NF-?B activation and IL-1ß expression. J Neuroinflammation 16:34 (2019). PubMed: 30755236
  • Song J  et al. LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway. Cancer Cell Int 19:60 (2019). PubMed: 30923462
  • Jiang L  et al. AICAR prolongs corneal allograft survival via the AMPK-mTOR signaling pathway in mice. Biomed Pharmacother 113:108558 (2019). PubMed: 30856534
  • Guo HH  et al. Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nat Commun 10:1981 (2019). PubMed: 31040273
  • Gao XL  et al. Upregulation of microRNA-335-5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model. Cytokine 110:466-478 (2018). PubMed: 29866515
  • Xu W  et al. TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway. Biomed Pharmacother 107:785-792 (2018). PubMed: 30142540
  • Li Y  et al. microRNA-300/NAMPT regulates inflammatory responses through activation of AMPK/mTOR signaling pathway in neonatal sepsis. Biomed Pharmacother 108:271-279 (2018). PubMed: 30223098
  • Yao S & Yan W Overexpression of Mst1 reduces gastric cancer cell viability by repressing the AMPK-Sirt3 pathway and activating mitochondrial fission. Onco Targets Ther 11:8465-8479 (2018). PubMed: 30555239
  • Zhou H  et al. Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission. Redox Biol 15:335-346 (2017). PubMed: 29306791
  • Wang X  et al. Sestrin2 and sestrin3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through AMPK and mTORC1 signaling. Oncotarget 8:90132-90143 (2017). PubMed: 29163816

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

登録